Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6499
    +0.0011 (+0.16%)
     
  • OIL

    82.92
    -0.44 (-0.53%)
     
  • GOLD

    2,334.70
    -7.40 (-0.32%)
     
  • Bitcoin AUD

    101,802.73
    -655.45 (-0.64%)
     
  • CMC Crypto 200

    1,429.02
    +4.92 (+0.35%)
     
  • AUD/EUR

    0.6072
    +0.0016 (+0.26%)
     
  • AUD/NZD

    1.0953
    +0.0022 (+0.20%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,631.58
    +160.11 (+0.92%)
     
  • FTSE

    8,066.29
    +21.48 (+0.27%)
     
  • Dow Jones

    38,508.16
    +4.47 (+0.01%)
     
  • DAX

    18,144.20
    +6.55 (+0.04%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout

4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout

The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.